Top Industry News

Samsung Biologics, a CDMO of biologics, has formed a strategic partnership for the long-term commercial manufacturing of Pfizer’s multi-product biosimilars portfolio and also provided an update on a new biomanufacturing…

The latest from CDMOs, CMOs, and suppliers featuring Lonza, WuXi Biologics, Euroapi, 3M, Sterling Pharma, Purolite, Cambrex, Catalent, Charles River, Wheeler Bio, Adcock Pharma, Upperton Pharma, Waters, Sartorius, ProBio, KBI…

A roundup of manufacturing news from Roche, Fosun Pharma and Intas. Highlights below.  * Roche To Divest Biomanufacturing Site in Vacaville, California   * Fosun Pharma To Build $106-M Drug-Product Mfg Facility…

A roundup of news from Eisai, Sandoz, AbCellera, and UK government. Highlights below.   * Eisai Subject of Ransomware Attack   * Sandoz Plans New HQ in Basel Following Spin-off from Novartis …

A US federal appeals court has upheld Purdue Pharma’s bankruptcy and reorganization plan, which involves a $6-billion settlement to resolve opioid-related litigation. The plan, which had received approval from a…

The US Department of Health and Human Services (HHS) has detailed its “Project NextGen” initiative, a $5-billion plan to accelerate and streamline the development of the next generation of vaccines…

The latest from CDMOs, CMOs, and suppliers featuring Olon, Thermo Fisher Scientific, Catalent, MilliporeSigma, Delpharm, uBriGene, GenScript Biotech, Aurigene, TriLink, Touchlight, JSR Life Sciences, KBI Biopharm, Selexis, eureKING, Resilience, AmbioPharm…

A roundup of news from Novo Nordisk, Novartis, Sun Pharma, Pfizer, and the Swedish government. Highlights below.   Manufacturing News * Swedish Gov’t Sets up $15-M Public-Private Consortium for Advanced Therapy Mfg Mergers…

The US Federal Trade Commission (FTC) is suing to block Amgen’s pending $27.8-billion acquisition of Horizon Therapeutics, a Dublin, Ireland-headquartered bio/pharmaceutical company specializing in rare diseases, on the grounds that…

The latest from CDMOs, CMOs, and suppliers featuring Wacker, Cambrex, AGC Biologics, Experic, NewBiologix, Ascend, SynCrest, and Avirmax CMC.    Chemicals/Chemical API Manufacturing * Wacker Completes $109-M Acquisition of ADL BioPharma* Cambrex…